You are here

AbbVie

Alector lays off 17% of staff after AbbVie-partnered Alzheimer's asset fails phase 2

Fierce Biotech

Tue, 11/26/24 - 11:05 am

Alzheimer's disease

clinical trials

What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine

Pharma Voice

Tue, 11/19/24 - 10:57 am

AbbVie bags EU nod for key drug from ImmunoGen takeover

Pharmaphorum

Mon, 11/18/24 - 11:10 am

Advantage BMS as AbbVie drug fails schizophrenia trials

Pharmaphorum

Mon, 11/11/24 - 11:24 am

Cerevel Therapeutics

clinical trials

Bristol Myers Squibb

Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in

Pharma Voice

Thu, 11/7/24 - 11:12 am

Vertex Pharmacuticals

Alpine Immune Sciences

Mariana Oncology

Fusion Pharmaceuticals

Longboard Pharmaceuticals

Aliada Therapeutics

AbbVie taps T-cell engager tech from EvolveImmune to build next-gen cancer biologics

First Word Pharma

Thu, 10/31/24 - 09:39 am

AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat

Investors Business Daily

Wed, 10/30/24 - 08:50 pm

AbbVie doubles down on Alzheimer’s with $1.4B Aliada buy

BioSpace

Mon, 10/28/24 - 11:41 am

Alzheimer's disease

Aliada Therapeutics

AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator

Fierce Biotech

Fri, 10/25/24 - 11:37 am

After rejections, AbbVie secures approval for Parkinson’s drug

BioPharma Dive

Thu, 10/17/24 - 08:52 pm

Parkinson's Disease

Skyrizi notches top pharma, Rx brand spot for Q3 2024

Medical Marketing and Media

Mon, 10/7/24 - 09:52 pm

Crohn's Disease

psoriatic arthritis

AbbVie cuts 2024 profit forecast citing R&D expenses

Reuters

Thu, 10/3/24 - 09:26 pm

Louisiana district court upholds state 340B contract pharmacy law

American Hospital Association

Wed, 10/2/24 - 10:01 pm

contract pharmacies

EU withdraws marketing authorisation for Abbvie's hepatitis C drug

Reuters

Wed, 10/2/24 - 11:16 am

Blue Shield of California bypasses PBMs to slash Humira prices by 90%

Pharmaphorum

Wed, 10/2/24 - 09:37 am

AbbVie seeks FDA approval for non-small cell lung cancer treatment

Pharmaceutical Business Review

Mon, 09/30/24 - 09:45 am

non-small cell lung cancer

AbbVie’s $8.7bn Parkinson’s disease drug shines in Phase III trial

Clinical Trials Arena

Mon, 09/30/24 - 09:15 am

Parkinson's Disease

clinical trials

AbbVie's Parkinson's disease drug meets main goal in late-stage trial

Reuters

Thu, 09/26/24 - 11:21 am

Parkinson's Disease

clinical trials

AbbVie’s RINVOQ shows promise in two Phase III atopic dermatitis trials

Clinical Trials Arena

Thu, 09/26/24 - 11:14 am

atopic dermatitis

clinical trials

New migraine drugs less effective than previous generation of triptan meds: BMJ study

Fierce Pharma

Thu, 09/19/24 - 09:29 pm

Pages